[Utilization of a new drug: H3452 in some functional abnormalities and especially those of ovulation].
D000311:Adrenal Glands / Q000503:physiopathology; D000328:Adult; D000568:Amenorrhea / Q000188:drug therapy; D001927:Brain Diseases / Q000150:complications; D003276:Contraceptives, Oral / Q000008:administration & dosage* / Q000494:pharmacology; D003338:Corpus Luteum; D003510:Cyclohexanes / Q000008:administration & dosage*; D005260:Female; D005640:Follicle Stimulating Hormone / Q000032:analysis; D006801:Humans; D007030:Hypothalamo-Hypophyseal System / Q000187:drug effects / Q000503:physiopathology; D007247:Infertility, Female / Q000188:drug therapy* / Q000209:etiology; D007248:Infertility, Male / Q000188:drug therapy*; D007986:Luteinizing Hormone / Q000032:analysis; D008297:Male; D008593:Menopause / Q000187:drug effects*; D008875:Middle Aged; D010049:Ovarian Diseases / Q000150:complications / Q000188:drug therapy
D003276:Contraceptives, Oral; D003510:Cyclohexanes; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone
A propos de l'utilisation d'un nouveau produit: le H3452 dans certaines anomalies fonctionnelles et en particulier dans celles de l'ovulation.